Investigational Therapy Exploring Treatment of Heart Failure Seeks to Stimulate Body’s Natural Healing Response

Published by
Published by: 
Krystle Barbour, Public Relations Coordinator
May 11, 2018
University of Minnesota first site in state to hold Phase III clinical trials for CardiAmp Therapy.

MINNEAPOLIS- May 02, 2018- University of Minnesota Medical School researchers to lead clinical trial for new, minimally invasive heart attack treatment. The University of Minnesota is the first site in the state to test the treatment that has shown improvements in patients’ quality of life and heart function.

The CardiAMP investigational therapy is a minimally invasive treatment for ischemic heart failure which occurs after a heart attack. The therapy includes a pre-procedure screening test. A small bone marrow sample is taken and screened to identify patients with a higher likelihood of benefitting from the treatment.

If a patient with University of Minnesota Health qualifies for the therapy, additional bone marrow is collected, which is immediately processed to concentrate the cells into the therapeutic dosage. The dose is then delivered through a catheterization procedure directly into the damaged portions of the heart. Therefore, the patient’s own cells are used in a therapy designed to stimulate the body’s natural healing response.

"Treatment of heart failure can be very challenging to the patient as well as for the care providers. CardiAMP is an investigational therapy using patients’ own cell lines to treat the failing heart muscle,” said Ganesh Raveendran, MD, Associate Professor of Medicine, Cardiovascular Division, University of Minnesota Medical School. “This therapy, if proven to be successful, could complement the current treatment modalities available to the patient and eventually reduce the need for LVAD therapy and heart transplantation."

Heart failure is a serious, chronic, and progressive condition in which the heart muscle is unable to pump enough blood to meet the body’s needs, and, for which typically there is no cure. However, many people with heart failure lead full, happy lives when the condition is managed properly. In 2015, an estimated 5.7 million Americans over the age of 20 were reported to have heart failure, according to the American Heart Association (AHA). The prevalence of heart failure continues to increase due to the aging population and the increase in major cardiovascular risk factors, including obesity and diabetes.

 

About the University of Minnesota Medical School The University of Minnesota Medical School is at the forefront of learning and discovery, transforming medical care and educating the next generation of physicians. Our graduates and faculty produce highimpact biomedical research and advance the practice of medicine. Visit med.umn.edu to learn how the University of Minnesota is innovating all aspects of medicine.

Contact: Krystle Barbour kbarbour@umn.edu 612-626-2767

Category: 

Share this post

You may also like:

Dr. Bernard Hering, Department of Medicine, and his team are modifying pancreatic cells from pigs in order to someday find a cure for diabetes. "We have now more and more reason to believe that we can turn this into a tangible benefit for diabetics and their families," Hering said. "We can make transplantation routine, commonplace, and on-demand."

Inspiring the next generation of neuroscience

Funky flavored jelly beans, tuning forks and observing a real human brain are just a few of the activities you can experience during the “Brain Awareness Campaign” visits that take place each year.

“Healthy Start, Healthy State” study finds children in Minnesota's childcare programs have better access to improved nutrition and physical activity practices.

MINNEAPOLIS - May 16, 2018 - Existing state and local programs focused on good nutrition and physical activities for children have led to measurable improvement in practices by the state’s child care programs between 2010 and 2016, says a new University of Minnesota Medical School.